Johnson & Johnson Stock Is Rising Because Its Earnings Beat Trumps a Sales Miss

1 month ago 20
PR Distribution

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

Updated Oct. 19, 2021 7:21 am ET / Original Oct. 19, 2021 6:46 am ET

  • Order Reprints
  • Print Article

Johnson & Johnson stock is gaining after the pharmaceutical giant reported earnings that topped analyst estimates.

Johnson & Johnson (JNJ) reported an adjusted profit of $2.60 a share, beating forecasts for $2.35 a share, on sales of $23.33 billion, missing expectations for $$23.72 billion.

“Our third-quarter results demonstrate solid performance...

Read Entire Article